Skip to main content
. 2020 Apr 21;42(3):404–413. doi: 10.1038/s41401-020-0397-3

Fig. 3. Effect of CAR treatment (20  mg/kg, p.o.) on LPS challenge (4  mg/kg, i.p., for 6  h)-induced changes in cardiomyocyte contractile properties.

Fig. 3

a Resting cell length; b peak shortening (PS); c maximal velocity of shortening (+dL/dt); d maximal velocity of relengthening (−dL/dt); e time-to-PS (TPS); and f time-to-90% relengthening (TR90). Mean ± SEM, n = 78–79 cells from four mice per group. *P < 0.05 vs the control group, #P < 0.05 vs the LPS group.